NCT06236841

A Phase I Study of XH-S004 in Healthy Volunteers

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Food Effects of XH-S004 Single and Multiple Ascending Doses in Healthy Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 90 (estimated)
• Sponsor: S-INFINITY Pharmaceuticals Co., Ltd · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This is a phase I, randomised, double-blind placebo-controlled, 3-part study to assess the safety, tolerability, pharmacokinetics and food effect of single and multiple oral doses of XH-S004 in healthy volunteers.

Conditions

• Healthy Adults

Interventions

Type	Name	Description
DRUG	XH-S004 tablet	XH-S004 tablets will be administered orally as per assigned treatment regimen on schedualed days.
DRUG	XH-S004 placebo tablet	XH-S004 placebo tablet (matched) will be administered orally as per assigned treatment regimen on schedualed days.

Timeline

• Start date: 2024-01-26
• Primary completion: 2025-01-31
• Completion: 2025-01-31
• First posted: 2024-02-01
• Last updated: 2024-02-05

Locations

1 site across 1 country: China